Retinitis Pigmentosa in Children: 5 Facts Families Should Know

The genetic disease that causes vision loss can affect all ages, including young people. Learn more about symptoms, risk factors and management.

7:00 AM

Author | Kari Branham, M.S., C.G.C.

Retinitis pigmentosa, or RP, is a group of related eye disorders that cause progressive vision loss. These disorders affect the retina, a layer at the back of the eye containing light-sensing cells.

LISTEN UP: Add the new Michigan Medicine News Break to your Alexa-enabled device, or subscribe to our daily audio updates on iTunes, Google Play and Stitcher.

Vision loss occurs as these light-sensing cells of the retina deteriorate. Initial symptoms include problems with night vision and peripheral vision, or side vision.

An estimated 100,000 Americans have RP. It can affect people of all ages, including children.

If your child or someone you know has been diagnosed with RP, here are a few important points that may help you better understand the condition:

1. Patients rarely lose all vision

If your child has RP, he or she may be able to retain good central and reading vision for many years — into adulthood. It is rare for people with RP to lose all of their vision, but many will eventually meet the definition of being legally blind (vision of 20/200 or worse, or visual fields of less than 20 degrees).

SEE ALSO: 3 Ways Genetic Counselors Provide Clarity on Eye Disease

2. It is a genetic disease

Some families with a child who has RP will know of another relative who has the condition. Sometimes several generations of a family are affected — but in other cases the disease is limited to one generation. In some families, the condition affects only males and females carry the disease-causing gene. Genetic testing can help to understand how the condition may run in your family.

3. Family history isn't required

RP is a genetic disease, but that doesn't mean that your child will have a family history of the condition. In fact, 40 to 50 percent of people with RP are the only ones in their families to have the condition. 

4. Help is available

Although RP has no cure, there are steps you can take to help your child. You can talk to a low-vision specialist in your child's school to create an individualized plan for schoolwork and for navigating the classroom more easily.

SEE ALSO: Why Does the Doctor Need a Photo of My Eye?

5. Treatments are being developed

Advances in gene therapy are yielding new options for treatment. The Food and Drug Administration has approved a gene therapy treatment — available at University of Michigan Kellogg Eye Center — to target a specific type of RP caused by mutations in the RPE65 gene.

Several other treatments are being developed for other types of RP. Other approaches, such as stem cell therapy and oral medications, are being investigated to help reshape the future for those with inherited retinal degenerations. 

To make an appointment in Kellogg's Inherited Retinal Degeneration Clinic, call 734-232-8080.


More Articles About: Eye Health Kellogg Eye Center Eye Disorders Genetic Disorders Hospitals & Centers Eye Care & Vision
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory
Vision Impairment as a Risk Factor for Dementia
The population of older adults living with dementia is expected to swell to nearly 14 million by 2050 and is estimated to cost the US economy more than 500 billion each year. In the absence of a cure for Alzheimer's disease, the primary cause of dementia, there's interest in understanding modifiable risk factors. In theory, getting a handle on the modifiable risk factors for dementia, would enable public health efforts to reduce cognitive decline in dementia at the population level. We've come a long way in understanding the risk factors for Alzheimer's disease and other related dementias. However, there's still work to be done. In this episode, we'll speak with Dr. Josh Ehrlich, a researcher at the University of Michigan, who has examined vision impairment as a risk factor for dementia.
wheelchair walker image
Health Lab
Spread of drug resistant bacteria linked to patient hand contamination and antibiotic use within nursing homes
A Michigan Medicine research team seeks to identify characteristics of patients within nursing homes, as well as the nursing home environment itself, that are associated with contamination by vancomycin-resistant enterococci.
graphic drawing of colonoscopy scan with large intestine vials patient on bed doctor
Health Lab
Investment in free follow up colonoscopies will pay off
Free colonoscopies for people whose at-home stool tests (such as Cologuard and FIT) turn up signs of potential cancer are now covered by insurance, and a study shows this will save money.
surgeons in OR with blue and teal scrubs with screen on and patient under teal sheet
Health Lab
Treating heart valve disease: What are your options?
Michigan Medicine’s head of cardiac surgery, Gorav Ailawadi, M.D, M.B.A., answers questions about different treatment options for heart valve disease.
Health Lab
How bedside musicians helped one family cope with tragedy
How the gifts of art and beside music and art programs helped one family cope with tragedy
pill bottle spilling yellow blue
Health Lab
Oral steroid usage increased across U.S., Taiwan and Denmark in past decade
Research from the University of Michigan finds that over the past decade, there has been a steady increase of oral steroids prescriptions not only in the United States, but in Taiwan and Denmark as well.